{
  "pmcid": "11326099",
  "sha256": "68cf9b39d98e0ace114698ad0ddca3c1c7af80445f66627b5f9b1d59a5ea457d",
  "timestamp_utc": "2025-11-09T23:14:59.112862+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.458803756796836,
    "reading_ease": 23.081199538638998,
    "word_count": 289
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of a Holistic Approach to Atherosclerosis Management"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were adults with risk factors for atherosclerosis, recruited from multiple healthcare centers."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults with risk factors for atherosclerosis, recruited from multiple healthcare centers."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received comprehensive vascular assessments and multidisciplinary care, while the control group received standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "To assess the effectiveness of a holistic approach in improving vascular health outcomes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in cardiovascular events over a 12-month period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised, with 100 in each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the intervention group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant reduction in cardiovascular events (mean difference = 5.2 events, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Mild adverse events were reported in 3% of the intervention group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institutes of Health."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}